<?xml version="1.0" encoding="UTF-8"?>
<p id="p0005">Leishmaniasis, a complex protozoan disease which is transmissible between animals and human (
 <xref rid="bb0135" ref-type="bibr">
  <italic>WHO technical report series.</italic>, 2010
 </xref>). According to the WHO around 12 million people are currently infected with leishmaniasis in 98 countries, over one billion people are at risk and the annual incidence is 0.7â€“1.2 million (
 <xref rid="bb0005" ref-type="bibr">Alvar et al., 2012</xref>). Clinical presentations of the disease are diverse, although two classical forms including visceral leishmaniasis (VL or kala-azar) and cutaneous form (CL) are predominant (
 <xref rid="bb0135" ref-type="bibr">
  <italic>WHO technical report series.</italic>, 2010
 </xref>). Cutaneous leishmaniasis, as the most wide-spread and neglected tropical disease consists of approximately 75% of the total case counts. The 6 countries that indicated the highest prevalence of CL including Afghanistan, Algeria, Brazil, Colombia, Iran and Syria (
 <xref rid="bb0005" ref-type="bibr">Alvar et al., 2012</xref>).
</p>
